Pharma exports to UK may rise up to 10% in FY27 as CETA takes effect

India's pharmaceutical exports to the UK are set to witness substantial growth thanks to the recently negotiated Comprehensive Economic and Trade Agreement. This groundbreaking agreement removes almost all tariffs on Indian drug products, enhancing the competitiveness of Indian generics and finished formulations. Preliminary data indicates promising trends in exports for this fiscal year, solidifying the UK's importance as a critical European market for India's pharmaceutical sector.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/BSWdxhj
via IFTTT